Loading
Everything in development, the medicines held by this cancer's subtypes, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for PD-L1-high gastric cancer, drawn from the whole corpus: 9 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Two assays with different thresholds leave patients near the cut-off in an uncertain position.
Most patients still progress within a year on chemo-immunotherapy.
How to combine PD-1 blockade with claudin 18.2 or HER2 therapy when targets overlap.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 11 changes by month →When this page itself was last checked or edited.
EFS HR 0.
A milestone in how this cancer is treated.
OS HR 0.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.